Real Estate
Live Price
Offline$47.62
+0.51% today
1Y Change
+21.47%
Window
Jun 26, 2025 → Jun 17, 2026
Coverage: 245 bars · Jun 26, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Omega Healthcare Investors, Inc. (OHI) is a Real Estate stock with a market cap of $13.99B and listed on NYSE. The stock last traded around $47.62 and up 21.5% across the available one-year price window (Jun 26, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +14.0%, EPS growth of +28.7%, a dividend yield of 5.7%. What stands out right now is revenue +14.0%, EPS +28.7%, free cash flow +23.3% with operating margin 64.3% and ROIC 7.9%. The dividend matters to the case here, with a current yield around 5.7%. Valuation already assumes a fairly strong business story at P/E 22.1 and price/sales 11.3. Stock Foundry combines OHI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OHI
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OHI Max Drawdown
-10.86%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for OHI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.1B
+21.0% YoY
FY Net Income
$416.7M
-2.4% YoY
Free Cash Flow
$627.1M
+8.4% YoY
Revenue Growth
+14.0%
EPS Growth
+28.7%
Gross Margin
85.0%
Net Margin
51.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 950M | 878M | 1.1B |
| Gross Profit | 533M | 1.0B | 935M | 863M | 1.1B |
| Operating Income | 749M | 660M | 489M | 392M | 566M |
| EBITDA | 1.2B | 947M | 811M | 1.0B | 993M |
| Net Income | 590M | 406M | 242M | 427M | 417M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 27M | 518M | 443M | 297M | 21M |
| Total Assets | 10.0B | 9.9B | 9.1B | 9.4B | 9.6B |
| Total Liabilities | 4.6B | 5.2B | 5.4B | 5.6B | 5.5B |
| Shareholder Equity | 5.2B | 4.5B | 3.6B | 3.6B | 3.9B |
| Total Debt | 4.3B | 4.8B | 5.1B | 5.3B | 5.3B |
| Net Debt | 4.2B | 4.3B | 4.6B | 5.0B | 5.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
722M
+15.4% YoY
Capital Expenditures
95M
-101.3% YoY
Free Cash Flow
627M
+8.4% YoY
Key ratios
Gross Margin
85.0%
Operating Margin
64.3%
Net Margin
51.0%
ROE
12.4%
Debt / Equity
0.86x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.